Status:
RECRUITING
New Approaches for Evaluating the Interchangeability of Reference Materials and Quality Controls (COMET-MPL)
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Hospitalization
All Conditions
Eligibility:
All Genders
18+ years
Brief Summary
Medical biology tests are essential to clinical decision-making. The European Regulation on in vitro diagnostic medical devices (EU/2017/746) requires metrological traceability of the values assigned ...
Detailed Description
The global in vitro diagnostics (IVD) market was valued at €91.1 billion in 2023 and is projected to reach €147.3 billion by 2030, reflecting its growing strategic importance in healthcare. Medical bi...
Eligibility Criteria
Inclusion
- Panel 1: adults ≥ 18 years of age.
- Panel 2: adults ≥ 18 years of age undergoing immunosuppressive treatment (cyclosporine, everolimus, tacrolimus, sirolimus).
Exclusion
- Protected patients (minors who are not emancipated, individuals who are unable to express their consent, etc.)
- Individuals who are not affiliated with a social security system
- Individuals under judicial protection
- Refusal to give consent to participate in the research
Key Trial Info
Start Date :
September 22 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 22 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT07173114
Start Date
September 22 2025
End Date
September 22 2026
Last Update
September 30 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Montpellier
Montpellier, France
2
University Hospital, Montpellier
Montpellier, France